Artículos de revistas sobre el tema "Stock vs flow"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Stock vs flow".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Piątkowski, Paweł. "STOCK FLOW ADJUSTMENT VS. STABILITY OF POLISH PUBLIC DEBT". PRACE NAUKOWE UNIWERSYTETU EKONOMICZNEGO WE WROCŁAWIU, n.º 521 (2018): 131–40. http://dx.doi.org/10.15611/pn.2018.521.13.
Texto completoEndriani, Santi. "Konsep Uang: Ekonomi Islam VS Ekonomi Konvensional". Anterior Jurnal 15, n.º 1 (1 de diciembre de 2015): 70–75. http://dx.doi.org/10.33084/anterior.v15i1.201.
Texto completoFikri, M. Ali, Biana Adha Inapty y Baiq Rosyida Dwi Astuti. "Direct Current (DC) vs Alternating Current (AC) Financial Transaction Flow in Holding and Non-Holding Companies". Prisma Sains : Jurnal Pengkajian Ilmu dan Pembelajaran Matematika dan IPA IKIP Mataram 10, n.º 2 (22 de abril de 2022): 352. http://dx.doi.org/10.33394/j-ps.v10i2.5090.
Texto completoVassallo, Paolo, Claudia Turcato, Ilaria Rigo, Claudia Scopesi, Andrea Costa, Matteo Barcella, Giulia Dapueto, Mauro Mariotti y Chiara Paoli. "Biophysical Accounting of Forests’ Value under Different Management Regimes: Conservation vs. Exploitation". Sustainability 13, n.º 9 (21 de abril de 2021): 4638. http://dx.doi.org/10.3390/su13094638.
Texto completoMATTIUCCI, S., R. CIMMARUTA, P. CIPRIANI, P. ABAUNZA, B. BELLISARIO y G. NASCETTI. "Integrating Anisakis spp. parasites data and host genetic structure in the frame of a holistic approach for stock identification of selected Mediterranean Sea fish species". Parasitology 142, n.º 1 (22 de agosto de 2014): 90–108. http://dx.doi.org/10.1017/s0031182014001103.
Texto completoLaoh, Lidya Chitra. "Dividend Payout Forecast : Multiple Linear Regression vs Genetic Algorithm-Neural Network". CogITo Smart Journal 5, n.º 2 (19 de diciembre de 2019): 252. http://dx.doi.org/10.31154/cogito.v5i2.210.252-265.
Texto completoSenarathne, Chamil W. y Jianguo Wei. "The impact of patent citation information flow regarding economic innovation on common stock returns: Volume vs. patent citations". International Journal of Innovation Studies 2, n.º 4 (diciembre de 2018): 137–52. http://dx.doi.org/10.1016/j.ijis.2019.02.001.
Texto completoKirchmeier, Delaney R., Alyssa Sheih, Salvatore Fiorenza, Alexandre V. Hirayama, Cassie Chou, Erik Kimble, Jordan Gauthier et al. "Recombinant CD19 Glycomutant Accurately and Reproducibly Detects CD19-Directed CAR-T Cells By Flow Cytometry". Blood 138, Supplement 1 (5 de noviembre de 2021): 1724. http://dx.doi.org/10.1182/blood-2021-148229.
Texto completoRubic-Schneider, Tina, Prithu Sundd, David Ledieu, Déborah Garcia, Jeannine Hehlen, Coline Burnet-Merlin, Benjamin Cochin de Billy et al. "Characterization of Two Anti-P-Selectin Monoclonal Antibodies (mAbs): Crizanlizumab Shows Comparable or Stronger Effects Versus Inclacumab across Cell Adhesion Assays in Vitro". Blood 138, Supplement 1 (5 de noviembre de 2021): 2032. http://dx.doi.org/10.1182/blood-2021-147318.
Texto completoBuda, Rocco, Chiara Bedon y Raffaele Pucinotti. "Retrofit of Existing Reinforced Concrete (RC) Buildings: Steel vs. RC Exoskeletons". Applied Sciences 12, n.º 22 (13 de noviembre de 2022): 11511. http://dx.doi.org/10.3390/app122211511.
Texto completoFriedman, J. J. "Vascular sensitivity and reactivity to norepinephrine in diabetes mellitus". American Journal of Physiology-Heart and Circulatory Physiology 256, n.º 4 (1 de abril de 1989): H1134—H1138. http://dx.doi.org/10.1152/ajpheart.1989.256.4.h1134.
Texto completoMendiola, Vincent Louie Ramos, Catherine Ly, Thuy Bui, Jennifer Wang, Jack Rodman, Karrune Woan, Eric Tam et al. "Superior Outcomes in Hispanic Patients Compared to Non-Hispanic Patients with Ph-Negative Acute Lymphoblastic Leukemia Using the Modified Pediatric-Based University of Southern California Acute Lymphoblastic Leukemia (USC ALL) Regimen for Newly Diagnosed ALL Patients in the Era of Novel Agents; A Retrospective Study". Blood 138, Supplement 1 (5 de noviembre de 2021): 3361. http://dx.doi.org/10.1182/blood-2021-150116.
Texto completoJohnson, Ned K. y Jill A. Marten. "Evolutionary Genetics of Flycatchers. II. Differentiation in the Empidonax difficilis Complex". Auk 105, n.º 1 (1 de enero de 1988): 177–91. http://dx.doi.org/10.1093/auk/105.1.177.
Texto completoUngfors, Anette, Niall J. McKeown, Paul W. Shaw y Carl André. "Lack of spatial genetic variation in the edible crab (Cancer pagurus) in the Kattegat–Skagerrak area". ICES Journal of Marine Science 66, n.º 3 (18 de enero de 2009): 462–69. http://dx.doi.org/10.1093/icesjms/fsn223.
Texto completoGhorani, E., J. Reading, J. Henry, M. Robert de Massy, R. Rosenthal, V. Turati, A. Furness et al. "P03.30 Tumur mutations drive dysfunctional T cell differentiation in lung cancer". Journal for ImmunoTherapy of Cancer 8, Suppl 2 (octubre de 2020): A35.1—A35. http://dx.doi.org/10.1136/jitc-2020-itoc7.68.
Texto completoClaessen, David, Anneke S. de Vos y André M. de Roos. "Bioenergetics, overcompensation, and the source–sink status of marine reserves". Canadian Journal of Fisheries and Aquatic Sciences 66, n.º 7 (julio de 2009): 1059–71. http://dx.doi.org/10.1139/f09-061.
Texto completoMendiola, Vincent Louie Ramos, Catherine Ly, Thuy Bui, Jennifer Wang, Jack Rodman, Karrune Woan, Eric Tam et al. "Outcomes in Adult Philadelphia-Positive Acute Lymphoblastic Leukemia Patients Using Tyrosine Kinase Inhibitors Combined with the Modified University of Southern California (USC ALL) Regimen without Pegaspargase in the Era of Novel Agents; A Retrospective Study". Blood 138, Supplement 1 (5 de noviembre de 2021): 4372. http://dx.doi.org/10.1182/blood-2021-150135.
Texto completoHirayama, Alexandre V., Ye Zheng, Mark R. Dowling, Alyssa Sheih, Tinh-Doan Phi, Delaney R. Kirchmeier, Abby W. Chucka et al. "Long-Term Follow-up and Single-Cell Multiomics Characteristics of Infusion Products in Patients with Chronic Lymphocytic Leukemia Treated with CD19 CAR-T Cells". Blood 138, Supplement 1 (5 de noviembre de 2021): 1749. http://dx.doi.org/10.1182/blood-2021-151571.
Texto completoKreitman, Robert J., Evgeny Arons, Sapolsky Jeffrey, Laura Roth, Hong Zhou, Maryalice Stetler-Stevenson, Wyndham H. Wilson et al. "Resolution of Hairy Cell Leukemia Minimal Residual Disease by Both BRAF and Clone-Specific Real-Time Quantitative PCR (RQ-PCR) After Treatment with Moxetumomab Pasudotox." Blood 120, n.º 21 (16 de noviembre de 2012): 2896. http://dx.doi.org/10.1182/blood.v120.21.2896.2896.
Texto completoWhite, Susan. "Amazon and Whole Foods: adventures in grocery shopping". CASE Journal 16, n.º 2 (27 de abril de 2020): 115–53. http://dx.doi.org/10.1108/tcj-11-2018-0118.
Texto completoChadha, Saurabh y Anil K. Sharma. "Determinants of capital structure: an empirical evaluation from India". Journal of Advances in Management Research 12, n.º 1 (5 de mayo de 2015): 3–14. http://dx.doi.org/10.1108/jamr-08-2014-0051.
Texto completoJesuraj, Nithya J., Julie M. Cole, Felipe Bedoya, Steven B. Wells, Guokui Qin, Sean Kevlahan, Marcela V. Maus y Andrew J. Ball. "A Novel Phase-Change Hydrogel Substrate for T Cell Activation Promotes Increased Expansion of CD8+ Cells Expressing Central Memory and Naive Phenotype Markers". Blood 128, n.º 22 (2 de diciembre de 2016): 3368. http://dx.doi.org/10.1182/blood.v128.22.3368.3368.
Texto completoFidai, Shiraz, Madina Sukhanova, Brian C. H. Chiu, Y. Lynn Lynn Wang, Wendy Stock, Peter A. Riedell, Sonali M. Smith, Elizabeth Hyjek y Girish Venkataraman. "TP53 Aberrations By FISH in CLL and Complex Karyotype at Transformation Predict for Worse Outcome in Diffuse Large B-Cell Lymphoma - Richter Transformation: A Single Institution Series of 75 DLBCL-RT Cases". Blood 132, Supplement 1 (29 de noviembre de 2018): 2984. http://dx.doi.org/10.1182/blood-2018-99-112242.
Texto completoP., Afsheena y Shijin Santhakumar. "Timeliness and persistence of conservative earnings in an emerging market". Journal of Financial Reporting and Accounting 18, n.º 3 (10 de junio de 2020): 483–503. http://dx.doi.org/10.1108/jfra-12-2018-0116.
Texto completoKumar, Alok. "Dynamic Style Preferences of Individual Investors and Stock Returns". Journal of Financial and Quantitative Analysis 44, n.º 3 (junio de 2009): 607–40. http://dx.doi.org/10.1017/s0022109009990020.
Texto completoKarol, Seth E., Thomas Alexander, Amit Budraja, Stanley Pounds, Kristin E. Canavera, Lei Wang, Joshua Wolf et al. "Venetoclax in Combination with High-Dose Chemotherapy Is Active and Well-Tolerated in Children with Relapsed or Refractory Acute Myeloid Leukemia". Blood 134, Supplement_1 (13 de noviembre de 2019): 178. http://dx.doi.org/10.1182/blood-2019-127716.
Texto completoZeidan, Amer M., Jan Philipp Philipp Bewersdorf, Vanessa Hasle, Ethan G. Thompson, Daniel Lopes de Menezes, Shelonitda Rose, Isaac Boss y Brian Fox. "Immune and Epigenetic Landscape of TP53-mutated Acute Myeloid Leukemia (AML) and Higher-Risk Myelodysplastic Syndromes (HR-MDS)". Blood 138, Supplement 1 (5 de noviembre de 2021): 3371. http://dx.doi.org/10.1182/blood-2021-146329.
Texto completoSoumerai, Jacob D., Anthony R. Mato, Ahmet Dogan, Venkatraman Seshan, Erel Joffe, Kelsey Flaherty, Jason Carter et al. "Zanubrutinib, Obinutuzumab, and Venetoclax in Chronic Lymphocytic Leukemia: Early MRD Kinetics Define a High-Risk Patient Cohort with Delayed Bone Marrow Undetectable MRD and Earlier Post-Treatment MRD Recurrence". Blood 138, Supplement 1 (5 de noviembre de 2021): 3753. http://dx.doi.org/10.1182/blood-2021-150961.
Texto completoHidalgo-Lopez, Juliana E., Gail J. Roboz, Brent Wood, Michael Borowitz, Elias J. Jabbour, Kelly Velasco, Ehab Elkhouly et al. "Heterogeneity of Minimal/Measurable Residual Disease (MRD) Practices in Adult B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) in the United States". Blood 138, Supplement 1 (5 de noviembre de 2021): 4478. http://dx.doi.org/10.1182/blood-2021-144353.
Texto completoNastiti, Pambayun Kinasih Yekti, Apriani Dorkas Rambu Atahau y Supramono Supramono. "THE DETERMINANTS OF WORKING CAPITAL MANAGEMENT: THE CONTEXTUAL ROLE OF ENTERPRISE SIZE AND ENTERPRISE AGE". Business, Management and Education 17, n.º 2 (9 de octubre de 2019): 94–110. http://dx.doi.org/10.3846/bme.2019.10409.
Texto completoAlhumaid, Muhned, Georgina S. Daher-Reyes, Aaron D. Schimmer, Andre C. Schuh, Anne Tierens, Caroline J. McNamara, Dawn Maze et al. "Prognostic Role of Multiparameter Flow Cytometry-Based Measurable Residual Disease Assessment in Patients with Acute Myeloid Leukemia Harboring DNMT3A/TET2/ASXL1 Mutation". Blood 136, Supplement 1 (5 de noviembre de 2020): 8–9. http://dx.doi.org/10.1182/blood-2020-138862.
Texto completoMurphy, Tracy, Stanley W. K. Ng, Ian King, Tong Zhang, Andrea Arruda, Narmin Ibrahimova, Jaime O. Claudio et al. "Inferior Outcomes with a High LSC17 Score Can be Improved with Flag-IDA". Blood 136, Supplement 1 (5 de noviembre de 2020): 35–36. http://dx.doi.org/10.1182/blood-2020-138943.
Texto completoKucukal, Erdem, Aaron Wolfe, Ryan Kocevar, Lalitha V. Nayak, Samuel Sowemimo-Coker, John Zak, Laurel Omert y Umut A. Gurkan. "Hypoxic Storage of Red Blood Cells: Assessment of Adhesion Properties Using a Standardized Endothelium-on-a-Chip Microfluidic Platform". Blood 138, Supplement 1 (5 de noviembre de 2021): 1072. http://dx.doi.org/10.1182/blood-2021-151270.
Texto completoKantarjian, Hagop M., Wendy Stock, Ryan D. Cassaday, Daniel J. DeAngelo, Elias Jabbour, Susan M. O'Brien, Matthias Stelljes et al. "Efficacy and Safety Outcomes in the Phase 3 INO-Vate Trial By Baseline CD22 Positivity Assessed By Local Laboratories". Blood 134, Supplement_1 (13 de noviembre de 2019): 1344. http://dx.doi.org/10.1182/blood-2019-122097.
Texto completoYilmaz, Musa, Hagop Kantarjian, Nicholas J. Short, Marina Konopleva, Tapan M. Kadia, Courtney D. DiNardo, Gautam Borthakur et al. "Hypomethylating Agent (HMA) Therapy and Venetoclax (VEN) with FLT3 Inhibitor "Triplet" Therapy Is Highly Active in Older/Unfit Patients with FLT3 Mutated AML". Blood 138, Supplement 1 (5 de noviembre de 2021): 798. http://dx.doi.org/10.1182/blood-2021-154143.
Texto completoCui, Lu, Cristabelle De Souza, Tristan Lerbs, Jessica Poyser, Maryam Kooshesh, Atif Saleem, Kerri Rieger et al. "Selective Targeting of Immune Modulatory Proteins to Mitigate Fibrosis and Inflammation in Sclerodermatous Graft-Vs-Host Disease". Blood 138, Supplement 1 (5 de noviembre de 2021): 644. http://dx.doi.org/10.1182/blood-2021-151223.
Texto completoMorodomi, Yosuke, Roberto Aiolfi, Eric Won, Sachiko Kanaji, Paul Schimmel, Zaverio M. Ruggeri y Taisuke Kanaji. "Sca-1 As a Marker of Stress-Induced Thrombopoiesis in Mice". Blood 134, Supplement_1 (13 de noviembre de 2019): 1068. http://dx.doi.org/10.1182/blood-2019-127446.
Texto completoBrown, Patrick A., Lingyun Ji, Xinxin Xu, Meenakshi Devidas, Laura Hogan, Michael J. Borowitz, Elizabeth A. Raetz et al. "A Randomized Phase 3 Trial of Blinatumomab Vs. Chemotherapy As Post-Reinduction Therapy in High and Intermediate Risk (HR/IR) First Relapse of B-Acute Lymphoblastic Leukemia (B-ALL) in Children and Adolescents/Young Adults (AYAs) Demonstrates Superior Efficacy and Tolerability of Blinatumomab: A Report from Children's Oncology Group Study AALL1331". Blood 134, Supplement_2 (21 de noviembre de 2019): LBA—1—LBA—1. http://dx.doi.org/10.1182/blood-2019-132435.
Texto completoBourreau, Jean-Pierre, Hamid S. Banijamali y Cyril E. Challice. "Modification of excitation–contraction coupling in cat ventricular myocardium following endocardial damage". Canadian Journal of Physiology and Pharmacology 71, n.º 3-4 (1 de marzo de 1993): 254–62. http://dx.doi.org/10.1139/y93-040.
Texto completoLachowiez, Curtis, Courtney D. DiNardo, Kiyomi Morita, Ken Furudate, Feng Wang, Tomoyuki Tanaka, Sa A. Wang et al. "Longitudinal Next Generation Sequencing Reveals the Clonal Hierarchy of IDH Mutated Clones and Impact on Survival in NPM1 Mutated AML". Blood 138, Supplement 1 (5 de noviembre de 2021): 607. http://dx.doi.org/10.1182/blood-2021-148971.
Texto completoZhang, Bo, Prajish Iyer, Meiling Jin, Elisa Ten Hacken, Zachary Cartun, Kevyn Hart, Laura Z. Rassenti et al. "Expression of Sf3b1-K700E accelerates the Development of Chronic Lymphocytic Leukemia in a Del(13q) Murine Model". Blood 136, Supplement 1 (5 de noviembre de 2020): 4–5. http://dx.doi.org/10.1182/blood-2020-139096.
Texto completoHines, Patrick C., Xiufeng Gao, Andrew Herppich, Wendy Hollon, Meera B. Chitlur, Janet L. Kwiatkowski y Michael Tarasev. "Ex Vivo Evaluation of Red Blood Cell Adhesion and Whole Blood Thrombosis in Pyruvate Kinase Deficiency". Blood 138, Supplement 1 (5 de noviembre de 2021): 923. http://dx.doi.org/10.1182/blood-2021-149744.
Texto completoKoller, Paul, Rima M. Saliba, Celina Ledesma, Gabriela Rondon, Uday Popat, Amin M. Alousi, Rohtesh S. Mehta et al. "Allogeneic Hematopoietic Cell Transplantation May Improve Long-Term Outcomes in Patients with Ph-like Acute Lymphoblastic Leukemia with CRLF2 Overexpression". Blood 134, Supplement_1 (13 de noviembre de 2019): 4598. http://dx.doi.org/10.1182/blood-2019-130645.
Texto completoLoh, Mignon L., Richard C. Harvey, Charles G. Mullighan, Stephen B. Linda, Meenakshi Devidas, Michael J. Borowitz, Andrew J. Carroll et al. "A BCR-ABL1-Like Gene Expression Profile Confers a Poor Prognosis In Patients with High-Risk Acute Lymphoblastic Leukemia (HR-ALL): A Report From Children's Oncology Group (COG) AALL0232". Blood 118, n.º 21 (18 de noviembre de 2011): 743. http://dx.doi.org/10.1182/blood.v118.21.743.743.
Texto completoTian, Linjie, Ana Paucarmayta, Rustin Lovewell, Karla Maloveste, Junshik Hong, Carly Hedgepath, Kwang Woon Kim et al. "A Novel Lair-1 Antibody Selectively Targets Acute Myeloid Leukemia (AML) Stem Cells". Blood 138, Supplement 1 (5 de noviembre de 2021): 3413. http://dx.doi.org/10.1182/blood-2021-147656.
Texto completoMostafa, Wael. "The relative information content of cash flows and earnings affected by their extremity". Managerial Finance 40, n.º 7 (3 de junio de 2014): 646–61. http://dx.doi.org/10.1108/mf-06-2013-0128.
Texto completoCasu, Carla, Rea Oikonomidau, Yatrik Shah, Elizabeta Nemeth, Tomas Ganz, Brian MacDonald y Stefano Rivella. "Concurrent Treatment with Minhepcidin and Deferiprone Improves Anemia and Enhances Reduction of Spleen Iron in a Mouse Model of Non-Transfusion Dependent Thalassemia". Blood 124, n.º 21 (6 de diciembre de 2014): 748. http://dx.doi.org/10.1182/blood.v124.21.748.748.
Texto completoFisher, Jack, Christopher J. Walker, Peter Johnson, Mark S. Cragg, Francesco Forconi, Yosef Landesman, Salim I. Khakoo y Matthew D. Blunt. "Selinexor Enhances NK Cell Activation Against Lymphoma Cells Via Downregulation of HLA-E". Blood 138, Supplement 1 (5 de noviembre de 2021): 2411. http://dx.doi.org/10.1182/blood-2021-144836.
Texto completoScarfò, Irene, Kathleen M. E. Gallagher, Mark B. Leick, Michael C. Kann, Justin Budka, Bharat Sowrirajan, Kim Nguyen, Rhine R. Shen, Adrian Bot y Marcela V. Maus. "Effects of Prior Exposure to Tec Kinase(BTK/ITK) Inhibitors on Kte-X19 Products". Blood 138, Supplement 1 (5 de noviembre de 2021): 3849. http://dx.doi.org/10.1182/blood-2021-146941.
Texto completoMandato, Elisa, Yanbo Sun, Vignesh Shanmugam, Il-Kyu Choi, Kyle T. Wright, Robert A. Redd, Lee N. Lawton et al. "Genetic Perturbation of CD70/CD27 Co-Stimulation Promotes the Development of Bcl6-Driven Diffuse Large B-Cell Lymphoma". Blood 138, Supplement 1 (5 de noviembre de 2021): 713. http://dx.doi.org/10.1182/blood-2021-153533.
Texto completo